Article Information
History
- December 20, 2021.
Article Versions
- Version 1 (November 25, 2021 - 09:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Bart Van Puyvelde1,
- Simon Daled1,
- Sander Willems2,
- Ralf Gabriels3,4,
- Anne Gonzalez de Peredo5,
- Karima Chaoui5,
- Emmanuelle Mouton-Barbosa5,
- David Bouyssié5,
- Kurt Boonen6,7,
- Christopher J. Hughes8,
- Lee A. Gethings8,
- Yasset Perez-Riverol9,
- Nic Bloomfield10,
- Stephen Tate10,
- Odile Schiltz5,
- Lennart Martens3,4,
- Dieter Deforce1 and
- Maarten Dhaenens1,*
- 1ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
- 2Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany
- 3VIB-UGent Center for Medical Biotechnology, VIB, 9000 Ghent, Belgium
- 4Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium
- 5Institut de Pharmacologie et de Biologie Structural (IPBS), Université de Toulouse, CNRS, UPS, Toulouse, France
- 6VITO Health, Mol, Belgium
- 7Centre for Proteomics, University of Antwerpen, Antwerp, Belgium
- 8Waters Corporation, Wilmslow, UK
- 9European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, UK
- 10Sciex, Concord, Ontario, Canada
- ↵*Corresponding author: Maarten Dhaenens (maarten.dhaenens{at}ugent.be)